SeriesFusion
Science, curated & edited by AI
First Ever  /  microbiology

Tuberculosis bacteria protect themselves with a near-impenetrable cell wall, and we can now watch in real-time as drugs try to fight through it.

Tuberculosis cells use a thick, waxy armor that successfully deflects most modern medicines. This new assay uses a split-luciferin molecule that only starts glowing once it successfully breaches the bacterial interior. Previous testing methods often required killing the bacteria to see if a drug worked, which prevented anyone from seeing the actual process of penetration. This technology provides a live broadcast of molecular movement across the cell wall for the first time. Developing better antibiotics becomes much faster when we can see exactly which chemical tweaks help a pill breach the fortress. It allows researchers to confirm a drug actually reached its target instead of just bouncing off the surface.

Original Paper

Split-luciferin Assay for Real-time Measurement of Cytosolic Molecular Accumulation in Live Mycobacteria

Dash, R.; Spira, A.; Lepori, I.; Bhandari, S.; Newkirk, S.; Lucas, N.; Chordia, M.; Siegrist, M. S.; Pires, M.

bioRxiv  ·  2025.11.02.686125

Tuberculosis causes over one million deaths annually and remains the leading cause of death from a single infectious agent. The emergence of multidrug-resistant Mycobacterium tuberculosis strains highlights the urgent need for new antibiotics, a pursuit hindered by its complex cell envelope. As most anti-tuberculosis agents act on intracellular targets, assessing cytosolic drug accumulation is critical. Conventional approaches generally quantify whole-cell association without resolving subcellul